全文获取类型
收费全文 | 26662篇 |
免费 | 2747篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 239篇 |
儿科学 | 766篇 |
妇产科学 | 683篇 |
基础医学 | 3711篇 |
口腔科学 | 616篇 |
临床医学 | 3140篇 |
内科学 | 5450篇 |
皮肤病学 | 375篇 |
神经病学 | 2573篇 |
特种医学 | 815篇 |
外科学 | 3525篇 |
综合类 | 615篇 |
一般理论 | 16篇 |
预防医学 | 2774篇 |
眼科学 | 481篇 |
药学 | 2336篇 |
1篇 | |
中国医学 | 30篇 |
肿瘤学 | 1287篇 |
出版年
2021年 | 381篇 |
2019年 | 363篇 |
2018年 | 426篇 |
2017年 | 340篇 |
2016年 | 334篇 |
2015年 | 392篇 |
2014年 | 567篇 |
2013年 | 829篇 |
2012年 | 1199篇 |
2011年 | 1229篇 |
2010年 | 708篇 |
2009年 | 593篇 |
2008年 | 1086篇 |
2007年 | 1261篇 |
2006年 | 1159篇 |
2005年 | 1213篇 |
2004年 | 1075篇 |
2003年 | 1149篇 |
2002年 | 1041篇 |
2001年 | 756篇 |
2000年 | 753篇 |
1999年 | 658篇 |
1998年 | 311篇 |
1997年 | 253篇 |
1996年 | 241篇 |
1995年 | 271篇 |
1994年 | 257篇 |
1993年 | 221篇 |
1992年 | 572篇 |
1991年 | 528篇 |
1990年 | 507篇 |
1989年 | 498篇 |
1988年 | 453篇 |
1987年 | 455篇 |
1986年 | 410篇 |
1985年 | 472篇 |
1984年 | 413篇 |
1983年 | 328篇 |
1982年 | 313篇 |
1981年 | 264篇 |
1980年 | 266篇 |
1979年 | 385篇 |
1978年 | 319篇 |
1977年 | 234篇 |
1976年 | 276篇 |
1975年 | 234篇 |
1974年 | 301篇 |
1973年 | 310篇 |
1972年 | 267篇 |
1971年 | 233篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
Faisal Karmali Csilla Haburcakova Wangsong Gong Charles C. Della Santina Daniel M. Merfeld Richard F. Lewis 《The Journal of neuroscience》2021,41(17):3879
Gravity is a pervasive environmental stimulus, and accurate graviception is required for optimal spatial orientation and postural stability. The primary graviceptors are the vestibular organs, which include angular velocity (semicircular canals) and linear acceleration (otolith organs) sensors. Graviception is degraded in patients with vestibular damage, resulting in spatial misperception and imbalance. Since minimal therapy is available for these patients, substantial effort has focused on developing a vestibular prosthesis or vestibular implant (VI) that reproduces information normally provided by the canals (since reproducing otolith function is very challenging technically). Prior studies demonstrated that angular eye velocity responses could be driven by canal VI-mediated angular head velocity information, but it remains unknown whether a canal VI could improve spatial perception and posture since these behaviors require accurate estimates of angular head position in space relative to gravity. Here, we tested the hypothesis that a canal VI that transduces angular head velocity and provides this information to the brain via motion-modulated electrical stimulation of canal afferent nerves could improve the perception of angular head position relative to gravity in monkeys with severe vestibular damage. Using a subjective visual vertical task, we found that normal female monkeys accurately sensed the orientation of the head relative to gravity during dynamic tilts, that this ability was degraded following bilateral vestibular damage, and improved when the canal VI was used. These results demonstrate that a canal VI can improve graviception in vestibulopathic animals, suggesting that it could reduce the disabling perceptual and postural deficits experienced by patients with severe vestibular damage.SIGNIFICANCE STATEMENT Patients with vestibular damage experience impaired vision, spatial perception, and balance, symptoms that could potentially respond to a vestibular implant (VI). Anatomic features facilitate semicircular canal (angular velocity) prosthetics but inhibit approaches with the otolith (linear acceleration) organs, and canal VIs that sense angular head velocity can generate compensatory eye velocity responses in vestibulopathic subjects. Can the brain use canal VI head velocity information to improve estimates of head orientation (e.g., head position relative to gravity), which is a prerequisite for accurate spatial perception and posture? Here we show that a canal VI can improve the perception of head orientation in vestibulopathic monkeys, results that are highly significant because they suggest that VIs mimicking canal function can improve spatial orientation and balance in vestibulopathic patients. 相似文献
993.
Journal of Neurology - Although effective symptomatic treatments for Parkinson’s disease (PD) have been available for some time, efficient and well-controlled drug delivery to the brain has... 相似文献
994.
995.
Ingemar S.J. Merkies Ivo N. van Schaik Jean‐Marc Lger Vera Bril Nan van Geloven Hans‐Peter Hartung Richard A. Lewis Gen Sobue John‐Philip Lawo Billie L. Durn David R. Cornblath Jan L. De Bleecker Claudia Sommer Wim Robberecht Mika Saarela Jerzy Kamienowski Zbigniew Stelmasiak Bjrn Tackenberg Orell Mielke 《Journal of the peripheral nervous system : JPNS》2019,24(1):48-55
Intravenous immunoglobulin (IVIG) is a potential therapy for chronic inflammatory demyelinating polyneuropathy (CIDP). To investigate the efficacy and safety of the IVIG IgPro10 (Privigen) for treatment of CIDP, results from Privigen Impact on Mobility and Autonomy (PRIMA), a prospective, open‐label, single‐arm study of IVIG in immunoglobulin (Ig)‐naïve or IVIG pre‐treated subjects (NCT01184846, n = 28) and Polyneuropathy And Treatment with Hizentra (PATH), a double‐blind, randomized study including an open‐label, single‐arm IVIG phase in IVIG pre‐treated subjects (NCT01545076, IVIG restabilization phase n = 207) were analyzed separately and together (n = 235). Efficacy assessments included change in adjusted inflammatory neuropathy cause and treatment (INCAT) score, grip strength and Medical Research Council (MRC) sum score. Adverse drug reactions (ADRs) and ADRs/infusion were recorded. Adjusted INCAT response rate was 60.7% in all PRIMA subjects at Week 25 (76.9% in IVIG pre‐treated subjects) and 72.9% in PATH. In the pooled cohort (n = 235), INCAT response rate was 71.5%; median time to INCAT improvement was 4.3 weeks. No clear demographic differences were noticed between early (responding before Week 7, n = 148) and late responders (n = 21). In the pooled cohort, median change from baseline to last observation was ?1.0 (interquartile range ?2.0; 0.0) point for INCAT score; +8.0 (0.0; 20.0) kPa for maximum grip strength; +3.0 (1.0; 7.0) points for MRC sum score . In the pooled cohort, 271 ADRs were reported in 105 subjects (44.7%), a rate of 0.144 ADRs per infusion. This analysis confirms the efficacy and safety of IgPro10, a recently FDA‐approved IVIG for CIDP, in a population of mainly pre‐treated subjects with CIDP [Correction added on 14 March 2019 after first online publication: the INCAT response rate has been corrected.]. 相似文献
996.
Stephanie D. Lewis Niranjan B. Butchi Mohammed Khaleduzzaman Tim W. Morgan Min Du Susan Pourciau David G. Baker Shizuo Akira Karin E. Peterson 《Journal of neurovirology》2008,14(6):492-502
Toll-like receptor 7 (TLR7) recognizes guanidine-rich single-stranded (ss) viral RNA and is an important mediator of peripheral
immune responses to several ssRNA viruses. However, the role that TLR7 plays in regulating the innate immune response to ssRNA
virus infections in specific organs is not as clear. This is particularly true in the central nervous system (CNS) where microglia
and astrocytes are often the first cells responding to virus infection instead of dendritic cells. In the current study, we
examined the mechanism by which TLR7 contributes to ssRNA virus-induced neuroinflammation using a mouse model of polytropic
retrovirus infection. The authors found that TLR7 was necessary for the early production of certain cytokines and chemokines,
including CCL2 and tumor necrosis factor (TNF) and was also involved in the early activation of astrocytes. However, TLR7
was not necessary for cytokine production and astrocyte activation at later stages of infection and did not alter viral pathogenesis
or viral replication in the brain. This suggests that other pathogen recognition receptors may be able to compensate for the
lack of TLR7 during retrovirus infection in the CNS. 相似文献
997.
Here the authors discuss evidence in human and animal models supporting two opposing views regarding the pathogenesis of human
immunodeficiency virus (HIV) in the central nervous system (CNS): (1) HIV infection in the CNS is a compartmentalized infection,
with the virus-infected macrophages entering the CNS early, infecting resident microglia and astrocytes, and achieving a state
of latency with evolution toward a fulminant CNS infection late in the course of disease; or alternatively, (2) events in
the periphery lead to altered monocyte/macrophage (MΦ) homeostasis, with increased CNS invasion of infected and/or uninfected
MΦs. Here the authors have reevaluated evidence presented in the favor of the latter model, with a discussion of phenotypic
characteristics distinguishing normal resident microglia with those accumulating in HIV encephalitis (HIVE). CD163 is normally
expressed by perivascular MΦs but not resident microglia in normal CNS of humans and rhesus macaques. In agreement with other
studies, the authors demonstrate expression of CD163 by brain MΦs in HIVE and simian immunodeficiency virus encephalitis (SIVE).
CNS tissues from HIV-sero positive individuals with HIVE or HIV-associated progressive multifocal leukoencephalopathy (PML)
were also examined. In HIVE, the authors further demonstrate colocalization of CD163 and CD16 (FcγIII recptor) gene expression,
the latter marker associated with HIV infection of monocyte in vivo and permissivity of infection. Indeed, CD163+ MΦs and microglia are often productively infected in HIVE CNS. In SIV infected rhesus macaques, CD163+ cells accumulate perivascularly, within nodular lesions and the parenchyma in animals with encephalitis. Likewise, parenchymal
microglia and perivascular MΦs are CD163+ in HIVE. In contrast to HIVE, CD163+ perivascular and parenchymal MΦs in HIV-associated PML were only associated with areas of demyelinating lesions. Interestingly,
SIV-infected rhesus macaques whose viral burden was predominantly at 1 × 106 copies/ml or greater developed encephalitis. To further investigate the relationship between CD163+/CD16+ MΦs/microglia in the CNS and altered homeostasis in the periphery, the authors performed flow-cytometric analyses of peripheral
blood mononuclear cells (PBMCs) from SIV-infected rhesus macaques. The results demonstrate an increase in the percent frequency
of CD163+/CD16+ monocytes in animals with detectable virus that correlated significantly with increased viral burden and CD4+ T-cell decline. These results suggest the importance of this monocyte subset in HIV/SIV CNS disease, and also in the immune
pathogenesis of lentiviral infection. The authors further discuss the potential role of CD163+/CD16+ monocyte/MΦ subset expansion, altered myeloid homeostasis, and potential consequences for immune polarization and suppression.
The results and discussion here suggest new avenues for the development of acquired immunodeficiency syndrome (AIDS) therapeutics
and vaccine design. 相似文献
998.
Neurocritical Care - 相似文献
999.
J.E. Liljenquist S.B. Lewis A.D. Cherrington B.C. Sinclair-Smith W.W. Lacy 《Metabolism: clinical and experimental》1981,30(12):1195-1199
Four normal and five insulin dependent diabetic men received a 2 h pharmacologic glucagon infusion (50 ng/kg/min) resulting in plasma glucagon levels (4400 pg/ml) similar to those seen in glucagonoma patients. In normal subjects in whom plasma insulin concentrations rose significantly (239 uU/ml) and the blood level of 15 of the 18 amino acids measured fell significantly. In contrast, in the diabetic men who secreted no insulin in response to glucagon (no rise in C-peptide levels), only 10 of 18 amino acid levels fell significantly. The branched chain amino acids valine, leucine and isoleucine, as well as tyrosine and phenylalanine were among the 8 amino acids which showed no change in response to glucagon in the diabetics. Thus, glucagon appears to have no acute affect on branched chain amino acid levels in man. 相似文献
1000.
Lawrence A Reduto Gregory C Freund Jay M Gaeta Richard W Smalling Brenda Lewis K.Lance Gould 《American heart journal》1981,102(6):1168-1177
Coronary angiography was performed on hospital admission in 37 patients with acute myocardial infarction (AMI). Thirty patients had total occlusion of the infarct-related coronary artery and seven patients had severe proximal stenoses with poor distal flow. In 20 of 30 patients with total occlusion, intracoronary (IC) infusion of streptokinase (SK) resulted in reperfusion of the distal coronary artery. Left ventricular (LV) performance was assessed before coronary angiography and at discharge from the hospital by use of gated cardiac blood pool imaging techniques. In patients evidencing reperfusion of the infarct-related coronary artery, mean (± SD) left ventricular ejection fraction (LVEF) increased from admission through discharge (46% ± 15% to 55% ± 10%, p = 0.002). In contrast, LVEF did not change from admission through discharge in patients with severe proximal stenoses alone or in patients with total occlusion who did not demonstrate reperfusion following SK administration (47% ± 17% vs 49% ± 18%, p = ns). In an additional 14 control patients with AMI who were not evaluated with coronary angiography, LVEF did not change from admission through discharge (46% ± 12% vs 48% ± 14%, p = ns). Quantitative thallium-201 perfusion imaging demonstrated an increase (p < 0.05) in thallium uptake in the infarct segment following coronary artery reperfusion. In contrast, thallium uptake did not change (p = ns) in the infarct segment in patients not evidencing angiographic coronary artery reperfusion. These data support the following: (1) Coronary artery thrombus occurs frequently in AMI and can be lysed by IC SK, and (2) reperfusion with IC SK in patients with evolving myocardial infarction results in myocardial salvage and improved LV performance through hospital discharge. 相似文献